Literature DB >> 22682515

Cell-penetrating peptides: breaking through to the other side.

Erez Koren1, Vladimir P Torchilin.   

Abstract

Cell-penetrating peptides (CPPs) have been previously shown to be powerful transport vector tools for the intracellular delivery of a large variety of cargoes through the cell membrane. Intracellular delivery of plasmid DNA (pDNA), oligonucleotides, small interfering RNAs (siRNAs), proteins and peptides, contrast agents, drugs, as well as various nanoparticulate pharmaceutical carriers (e.g., liposomes, micelles) has been demonstrated both in vitro and in vivo. This review focuses on the peptide-based strategy for intracellular delivery of CPP-modified nanocarriers to deliver small molecule drugs or DNA. In addition, we discuss the rationales for the design of 'smart' pharmaceutical nanocarriers in which the cell-penetrating properties are hidden until triggered by exposure to appropriate environmental conditions (e.g., a particular pH, temperature, or enzyme level), applied local microwave, ultrasound, or radiofrequency radiation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682515     DOI: 10.1016/j.molmed.2012.04.012

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  171 in total

1.  Novel cell-penetrating peptide-adaptors effect intracellular delivery and endosomal escape of protein cargos.

Authors:  John C Salerno; Verra M Ngwa; Scott J Nowak; Carol A Chrestensen; Allison N Healey; Jonathan L McMurry
Journal:  J Cell Sci       Date:  2016-01-22       Impact factor: 5.285

2.  Single quantum dot tracking reveals that an individual multivalent HIV-1 Tat protein transduction domain can activate machinery for lateral transport and endocytosis.

Authors:  Yasuhiro Suzuki; Chandra Nath Roy; Warunya Promjunyakul; Hiroyasu Hatakeyama; Kohsuke Gonda; Junji Imamura; Biju Vasudevanpillai; Noriaki Ohuchi; Makoto Kanzaki; Hideo Higuchi; Mitsuo Kaku
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

3.  New engineered antibodies against prions.

Authors:  Nives Škrlj; Marko Dolinar
Journal:  Bioengineered       Date:  2013-08-09       Impact factor: 3.269

Review 4.  Designing protein-based biomaterials for medical applications.

Authors:  Jennifer E Gagner; Wookhyun Kim; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

5.  Characterization of endocytic uptake of MK2-inhibitor peptides.

Authors:  Jamie Brugnano; James McMasters; Alyssa Panitch
Journal:  J Pept Sci       Date:  2013-08-23       Impact factor: 1.905

Review 6.  Getting across the cell membrane: an overview for small molecules, peptides, and proteins.

Authors:  Nicole J Yang; Marlon J Hinner
Journal:  Methods Mol Biol       Date:  2015

7.  Tmem100 Is a Regulator of TRPA1-TRPV1 Complex and Contributes to Persistent Pain.

Authors:  Hao-Jui Weng; Kush N Patel; Nathaniel A Jeske; Sonya M Bierbower; Wangyuan Zou; Vinod Tiwari; Qin Zheng; Zongxiang Tang; Gary C H Mo; Yan Wang; Yixun Geng; Jin Zhang; Yun Guan; Armen N Akopian; Xinzhong Dong
Journal:  Neuron       Date:  2015-01-29       Impact factor: 17.173

8.  An arsenical-maleimide for the generation of new targeted biochemical reagents.

Authors:  Aparna Sapra; Colin Thorpe
Journal:  J Am Chem Soc       Date:  2013-02-08       Impact factor: 15.419

9.  Polyarginine Interacts More Strongly and Cooperatively than Polylysine with Phospholipid Bilayers.

Authors:  Aaron D Robison; Simou Sun; Matthew F Poyton; Gregory A Johnson; Jean-Philippe Pellois; Pavel Jungwirth; Mario Vazdar; Paul S Cremer
Journal:  J Phys Chem B       Date:  2016-08-29       Impact factor: 2.991

Review 10.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.